Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.1200 (8.52%) ($98.0800 - $112.1900) on Wed. Apr. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.21% (three month average) | RSI | 73 | Latest Price | $101.1200(8.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWC(48%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -3.105% in a week (0% probabilities). VIXM(-25%) VXX(-16%) UUP(-16%) UNG(-2%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.105% (StdDev 6.21%) | Hourly BBV | 0 () | Intraday Trend | -3.3% | | | |
|
5 Day Moving Average | $96.24(5.07%) | 10 Day Moving Average | $95.55(5.83%) | 20 Day Moving Average | $88.67(14.04%) | To recent high | -6.3% | To recent low | 59.6% | Market Cap | $1.625b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |